Category: Money tips Release Date: 2007-03-02
Source: Source up to invest in
Star Lake Technology (600,866): The company was established with the previous co-operation on the Haibo Haibo De Star gene chip company, is China's largest investment in modern bio-chip, high-tech enterprise, is the only large-scale production and supply of commercial microarray products, professional公司. Company and work together to build on last Haibo Haibo De Star has mass production of human expression profile gene chip, gene expression profile classification of chips, drug screening chip series (mouse expression profile gene chip) and disease-related expression profile of the four chips series of gene chip products. Microarray series of research and development work is progressing well, Mediterranean anemia, G6PD testing, HLA characteristic spectrum of diagnostic chips, and for the detection of genetically modified commodities and commodity inspection chip family is expected to be launched, the product of the continued expansion and sales will no doubt brought about by the parent company Seiko significant amount of money.
Company is the only production of nucleotides food additives listed companies, a number of products, production scale and market share ranks first in China. In May of this year, China's Ministry of Commerce filed a nucleotide food additive to make definitive anti-dumping cases the final ruling, the decision made in Japan, South Korea imported nucleotides food additives levy 25% -119% of the high anti-dumping tax, anti-dumping period of 5 years. This will greatly enhance the competitiveness of the company to further expand market share, improve the company's business performance. In addition, the company invested 352 million annual output of 30,000 tons of lysine project was completed and commissioned in January 2005 as the world's second largest production base of amino acids. GF Securities Company holds 646.7 million shares, 0.32% of its total share capital. With the GF Securities backdoor listing, the company investment income is expected to increase in the outbreak of stars.
The secondary market, the stock had a wave of pre-shock upside, the main signs of significant funding large-scale intervention, the latter affected by the broader market fell sharply, now back to pre-launch platform near the center line constitutes a major double-dip shape, the disk has been shown Xi Pan very good, afternoon is expected to end finishing, break up, investors may be great concern.
Historical Information: G Star Lake (600,866): the market outlook is expected to break out of the upward market, can be highly concerned about August 7, 2006
Source: Kim Merrill Lynch Investment Authors: Huang Min Hong
G Star Lake (600,866): The company was established with the previous co-operation on the Haibo Haibo De Star gene chip company, is China's largest investment in modern bio-chip, high-tech enterprise, is the only large-scale production and supply of commercial microarray products, professional公司. Company and work together to build on last Haibo Haibo De Star has mass production of human expression profile gene chip, gene expression profile classification of chips, drug screening chip series (mouse expression profile gene chip) and disease-related expression profile of the four chips series of gene chip products. Microarray series of research and development work is progressing well, Mediterranean anemia, G6PD testing, HLA characteristic spectrum of diagnostic chips, and for the detection of genetically modified commodities and commodity inspection chip family is expected to be launched, the product of the continued expansion and sales will no doubt brought about by the parent company Seiko significant amount of money.
Company is the only production of nucleotides food additives listed companies, a number of products, production scale and market share ranks first in China. In May of this year, China's Ministry of Commerce filed a nucleotide food additive to make definitive anti-dumping cases the final ruling, the decision made in Japan, South Korea imported nucleotides food additives levy 25% -119% of the high anti-dumping tax, anti-dumping period of 5 years. This will greatly enhance the competitiveness of the company to further expand market share, improve the company's business performance. In addition, the company invested 352 million annual output of 30,000 tons of lysine project was completed and commissioned in January 2005 as the world's second largest production base of amino acids. Company's main business in the first quarter of 2006 revenue and net profit growth of 53.11 percent respectively, a substantial year on year and 98.87%, showing explosive growth, the year is also very gratifying business trend.
The secondary market, the stock had a wave of pre-shock upside, the main signs of significant funding large-scale intervention, the latter affected by the broader market fell sharply, now back to pre-launch platform in the vicinity, and by the years of the double line and half-line support, disk show that Xi Pan has been very good, Wednesday once again upside, MA Jin Cha issued buy signals, market outlook is expected to break out of the upward market, can be great concern.
